Yeztugo, a twice-yearly shot, could be the catalyst for stopping a recent spike in new HIV diagnoses. It's now available in ...
The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.
For decades, HIV treatment has depended on one hard truth: once medication stops, the virus usually comes roaring back. Modern antiretroviral drugs can suppress HIV so effectively that many people ...
The six-monthly anti-HIV jab, which prevents getting HIV through sex, is now stocked for free at 360 government clinics in ...
In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in some who had been infected. Importantly, this was when experts still ...
KANSAS CITY, Mo. — National Women and Girls HIV/AIDS Awareness Day is recognized March 10. Kansas City nonprofit BlaqOut, which works to improve healthcare access while creating a safe space for KC's ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...
Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci ...
The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results